| |
| |
|
| Insider
Information: |
Versant Ventures Vi Gp-Gp, Llc |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
3,589,271 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,589,271 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
10% Owner |
2020-01-02 |
0 |
2020-01-09 |
2,846,941 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
|
0 |
2020-06-18 |
742,330 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
742,330 |
|
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-09 |
4/A |
AS |
$20.21 |
$334,011 |
I/I |
(16,527) |
2,846,941 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-09 |
4 |
AS |
$20.21 |
$334,011 |
I/I |
(16,527) |
3,203,067 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-08 |
4 |
AS |
$19.80 |
$442,886 |
I/I |
(22,368) |
3,219,594 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-08 |
4/A |
AS |
$19.80 |
$442,886 |
I/I |
(22,368) |
2,863,468 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-07 |
4 |
AS |
$20.05 |
$283,948 |
I/I |
(14,162) |
3,241,962 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-07 |
4/A |
AS |
$20.05 |
$283,948 |
I/I |
(14,162) |
2,885,836 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-06 |
4 |
AS |
$17.68 |
$1,043,102 |
I/I |
(53,392) |
3,256,124 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-06 |
4/A |
AS |
$17.68 |
$1,043,102 |
I/I |
(53,392) |
2,899,998 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-03 |
4 |
AS |
$19.18 |
$61,485 |
I/I |
(3,200) |
3,309,516 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-03 |
4/A |
AS |
$19.18 |
$61,485 |
I/I |
(3,200) |
2,953,390 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-02 |
4/A |
AS |
$19.89 |
$322,685 |
I/I |
(15,852) |
3,640,733 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
I/I |
25,486 |
11,803 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-02 |
4 |
AS |
$0.00 |
$0 |
I/I |
(709,629) |
0 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-01-02 |
4 |
AS |
$19.89 |
$322,685 |
I/I |
(15,852) |
3,996,859 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
